Filing Details

Accession Number:
0001209191-15-082472
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-30 16:03:46
Reporting Period:
2015-11-25
Filing Date:
2015-11-30
Accepted Time:
2015-11-30 16:03:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1401914 Cerulean Pharma Inc. CERU Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1205236 R David Walt C/O Cerulean Pharma Inc.
840 Memorial Drive
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-11-25 5,417 $3.37 5,417 No 4 P Direct
Common Stock Acquisiton 2015-11-27 6,700 $3.28 12,117 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $3.35 to $3.41 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.
  2. Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $3.25 to $3.32 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.